For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Source: Thailand Medical News  Feb 03, 2019  7 years, 1 minute ago

Hetero Pharmaceuticals launches generic lapatinib in India

Presented by
Hetero Pharmaceuticals launches generic lapatinib in India
Source: Thailand Medical News  Feb 03, 2019  7 years, 1 minute ago
Hetero, one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs, announces the launch of generic version of lapatinib (250 mg) tablets in India. The product is marketed and distributed under the brand name ‘Hertab’ by Hetero Healthcare Ltd. It is made available in two SKUs, each consisting of 30 tablets and 150 tablets.
Hetero Pharmaceuticals
Hertab (lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medication Capecitabine or letrozole, which together, inhibit the growth of cancer cells in patients.

The price of brandname lapatinib in the US is about US$8,500 for 150 tablets whereas the generic version from India is only US$ 350 per 150 tablets, representing a huge cost saving for patients suffering from advanced breast cancer.

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics.

MOST READ

Jan 31, 2026  3 days ago
Nikhil Prasad
Jan 27, 2026  7 days ago
Nikhil Prasad
Jan 27, 2026  8 days ago
Nikhil Prasad
Jan 26, 2026  8 days ago
Nikhil Prasad
Jan 25, 2026  9 days ago
Nikhil Prasad
Jan 24, 2026  10 days ago
Nikhil Prasad
Jan 23, 2026  12 days ago
Nikhil Prasad
Jan 22, 2026  12 days ago
Nikhil Prasad
Jan 21, 2026  13 days ago
Nikhil Prasad
Jan 20, 2026  14 days ago
Nikhil Prasad
Jan 18, 2026  16 days ago
Nikhil Prasad
Jan 18, 2026  16 days ago
Nikhil Prasad
Jan 17, 2026  17 days ago
Nikhil Prasad
Jan 14, 2026  20 days ago
Nikhil Prasad
Jan 14, 2026  21 days ago
Nikhil Prasad
Jan 13, 2026  21 days ago
Nikhil Prasad
Jan 12, 2026  22 days ago
Nikhil Prasad
Jan 12, 2026  23 days ago
Nikhil Prasad
Jan 11, 2026  23 days ago
Nikhil Prasad